Janux Therapeutics Growth Metrics (2021-2026) | JANX

Growth Metrics Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter) -0.03M0.06M-0.01M0.02M-0.01M-0.12M0.04M-0.00M-0.06M0.18M-0.75M0.78M
EBITDA Margin Growth (3y) (Quarter) -0.10M0.11M-0.72M0.06M0.01M
EBITDA Margin Growth (5y) (Quarter) -0.03M
EBITDA Margin (QoQ) (Quarter) -0.07M0.04M0.01M-0.00M0.01M-0.03M0.04M-0.03M-0.10M0.13M-0.00M-0.10M0.15M-0.80M
EBIT Margin Growth (1y) (Quarter) -0.03M0.06M-0.01M0.02M-0.01M-0.12M0.04M-0.00M-0.06M0.18M-0.75M0.78M
EBIT Margin Growth (3y) (Quarter) -0.10M0.11M-0.72M0.06M0.01M
EBIT Margin Growth (5y) (Quarter) -0.03M
EBIT Margin (QoQ) (Quarter) -0.07M0.04M0.01M-0.00M0.01M-0.03M0.04M-0.03M-0.10M0.13M-0.00M-0.10M0.15M-0.80M
EBT Margin Growth (1y) (Quarter) -0.24M-0.10M0.42M0.03M0.04M-0.28M0.19M0.01M-1.88M0.18M-7.67M7.65M
EBT Margin Growth (3y) (Quarter) -2.08M-0.20M-7.06M0.17M0.13M
EBT Margin Growth (5y) (Quarter) -0.08M
EBT Margin (QoQ) (Quarter) -0.07M-0.59M0.64M-0.22M0.07M-0.07M0.24M-0.21M-0.24M0.41M0.06M-2.10M1.82M-7.45M
Enterprise Value Growth (1y) (Quarter) -4,699.24%10.12%12.58%12.79%12.27%14.40%-3.23%-5.20%-105.68%-113.09%-88.16%-197.99%-55.60%-54.11%-50.30%5.72%5.70%
Enterprise Value Growth (3y) (Quarter) -253.12%-17.92%-19.30%-39.83%-41.08%-41.13%-42.92%-43.51%-44.52%
Enterprise Value Growth (5y) (Quarter) -162.11%
Enterprise Value (QoQ) (Quarter) 1.70%3.24%3.67%1.91%4.39%3.47%3.10%4.29%-15.31%1.63%-89.45%0.84%-1.82%-55.79%1.08%1.79%0.70%2.27%1.05%
FCF Margin Growth (1y) (Quarter) -0.22M0.10M-0.02M0.02M0.01M-0.12M0.02M649.00-0.05M0.14M0.00M0.03M
FCF Margin Growth (3y) (Quarter) -0.27M0.12M0.00M0.06M0.04M
FCF Margin Growth (5y) (Quarter) -0.18M
FCF Margin (QoQ) (Quarter) -0.28M0.08M-0.02M-0.01M0.04M-0.04M0.03M-0.03M-0.08M0.10M0.01M-0.08M0.11M-0.03M
Interest Coverage Ratio Growth (1y) (Quarter) -218.48%-40.14%-24.06%-119.52%85.34%91.50%89.10%-234.86%-849.00%-188.57%-351.23%
Interest Coverage Ratio Growth (3y) (Quarter) 61.78%8.66%11.72%-0.03%11.61%-30.36%
Interest Coverage Ratio Growth (5y) (Quarter) 46.20%
Interest Coverage Ratio (QoQ) (Quarter) -18.14%-4.61%-11,012.98%98.98%-4.58%-85.09%39.36%-137.31%-71.86%27.84%
Net Margin Growth (1y) (Quarter) -0.24M-0.10M0.42M0.03M0.04M-0.28M0.19M0.01M-1.88M0.18M-7.67M7.65M
Net Margin Growth (3y) (Quarter) -2.08M-0.20M-7.06M0.17M0.13M
Net Margin Growth (5y) (Quarter) -0.08M
Net Margin (QoQ) (Quarter) -0.07M-0.59M0.64M-0.22M0.07M-0.07M0.24M-0.21M-0.24M0.41M0.06M-2.10M1.82M-7.45M
Operating Margin Growth (1y) (Quarter) -0.03M0.06M-0.01M0.02M-0.01M-0.12M0.04M-0.00M-0.06M0.18M-0.75M0.78M
Operating Margin Growth (3y) (Quarter) -0.10M0.11M-0.72M0.06M0.01M
Operating Margin Growth (5y) (Quarter) -0.03M
Operating Margin (QoQ) (Quarter) -0.07M0.04M0.01M-0.00M0.01M-0.03M0.04M-0.03M-0.10M0.13M-0.00M-0.10M0.15M-0.80M
Return on Assets Growth (1y) (Quarter) 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-1.00-1.000.00M0.00M1.001.000.00M
Return on Assets Growth (3y) (Quarter) -1.00-1.000.00M0.00M0.00M0.00M0.00M
Return on Assets (QoQ) (Quarter) 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Capital Employed Growth (1y) (Quarter) -0.00M-0.00M-935.00-831.00-437.00-71.00766.000.00M876.00821.00297.00-449.00-170.00-447.00-549.00
Return on Capital Employed Growth (3y) (Quarter) -719.00-265.00128.0096.00269.00303.00514.00
Return on Capital Employed (QoQ) (Quarter) -331.00-338.00-295.00-194.00-188.00-258.00-191.00200.00179.00579.00419.00-300.00123.0055.00-327.00-22.00-154.00-47.00
Return on Sales Growth (1y) (Quarter) -24.00-10.0042.003.004.00-28.0019.001.00-188.0018.00-767.00-82.00128.00-0.00M765.0042.0073.00
Return on Sales Growth (3y) (Quarter) -208.00-20.00-706.00-79.00-56.00-0.00M17.00-39.0013.00
Return on Sales Growth (5y) (Quarter) -8.00
Return on Sales (QoQ) (Quarter) -7.00-59.0064.00-22.007.00-7.0024.00-21.00-24.0041.006.00-210.00182.00-745.00691.001.00-0.00M0.00M-32.0031.00